Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-18

FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Laurus Labs Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic fixed-dose combination emtricitabine/tenofovir disoproxil fumarate by Laurus Labs Limited for HIV-1 in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

SUPPL AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)